ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment

Study limitation reported by the research below: “The finding challenges the widely held clinical assumption that anti-PLA2R positivity indicates primary (idiopathic) MN and excludes secondary causes — clinicians should revisit this heuristic in their practice.”

Papers